Results 101 to 110 of about 30,778 (256)

New Bifunctional Chelator 3p-C-NEPA for Potential Applications in Lu(III) and Y(III) Radionuclide Therapy and Imaging [PDF]

open access: gold, 2020
Xiang Sun   +8 more
openalex   +1 more source

Mass spectrometry in ocular drug research

open access: yesMass Spectrometry Reviews, Volume 45, Issue 1, Page 37-68, January/February 2026.
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo   +6 more
wiley   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

open access: yesMedicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller   +5 more
wiley   +1 more source

Investigation of inter‐source and intra‐source spectral variations in an electronic brachytherapy source using spectral measurements and Monte Carlo simulations

open access: yesMedical Physics, Volume 53, Issue 1, January 2026.
Abstract Background The Xoft electronic brachytherapy source is commonly used to treat superficial lesions and tumors located at shallow depths. However, uncertainties in material composition and geometry, mainly arising due to the manual assembly of the x‐ray tube components, contribute to inter‐source variability in the tube output spectrum.
Azin Esmaelbeigi   +6 more
wiley   +1 more source

A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy [PDF]

open access: bronze, 2020
Sander C. Ebbers   +5 more
openalex   +1 more source

Accuracy and precision of few‐time‐points renal dosimetry for [177Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling

open access: yesMedical Physics, Volume 53, Issue 1, January 2026.
Abstract Background Determination of time‐integrated activity (TIA) with a reduced number of imaging sessions is essential for minimizing patient burden and clinical workload in the dosimetry of [177Lu]Lu‐PSMA‐617. One approach to achieve this is by performing single‐time‐point (STP) dosimetry.
Assyifa R. Hakim   +9 more
wiley   +1 more source

Nanotechnology‐Enhanced Approaches for Early Cancer Diagnosis

open access: yesNano Select, Volume 7, Issue 1, January 2026.
Conventional MRI and PET provide limited sensitivity and contrast for precise brain lesion detection. In contrast, radiolabeled nanoparticlebased PET imaging enables enhanced signal specificity and sensitivity. By integrating multifunctional nanoprobes, this platform improves multimodal imaging performance, allowing more accurate visualization of ...
Jongmoo Lee   +5 more
wiley   +1 more source

High‐Loaded Bismuth Oxide/Copper Silicone Rubber Composites and Their Application as Shielding Collar for I‐131 Treated Thyroid Cancer Patients

open access: yesSPE Polymers, Volume 7, Issue 1, January 2026.
Development of high‐filler‐content silicone rubber composites containing up to 80 wt% bismuth oxide or copper, demonstrating significant I‐131 attenuation with retained flexibility and durability. ABSTRACT The development of flexible, non‐lead radiation‐shielding materials remains a critical challenge, particularly for I‐131 protection, where no ...
Kanaungnit Kingpetch   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy